Ensysce Biosciences, Inc. (ENSC) stock
ENSCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.36−0.00 (-0.17%)
Close on Nov 20, 2026Market cap $7.00MP/E –Yield –
Ensysce Biosciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Ensysce Biosciences's free cash flow for the twelve months ending Dec 31, 2025 was -$7.93M. For fiscal 2025 it was -$7.93M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$7.93M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$1.53M | – |
See a number that looks wrong?